Prolonged Progression-Free Survival with Extended Cycle Streptozotozin/5-FU Chemotherapy in Patients with Metastatic Pancreatic Neuroendocrine Tumors

#990

Introduction: The treatment of pancreatic neuroendocrine tumors with streptozotocin-based chemotherapy is well-established.

Aim(s): However, the question is when to stop treatment once tumor stabilization has been achieved.

Materials and methods: We report our single center experience in the treatment of 14 patients with neuroendocrine tumors of the pancreas with a combination of streptozotocin and 5-FU.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Schrader J, Zimmermann-Fraedrich K, Benten D, Pace A, Bläker M,

Keywords: chemotherapy,